Corbus Pharmaceuticals Holdings (CRBP) Debt Ratio (2013 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Debt Ratio of 0.07 for Q2 2024, down 83.14% year-over-year from 0.42 in Q3 2023, and down 30.36% quarter-over-quarter from 0.1 in Q1 2024.
Corbus Pharmaceuticals Holdings (CRBP) Debt Ratio (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.07 for Q2 2024.
- In Q2 2024, Debt Ratio fell 83.14% year-over-year to 0.07; the TTM figure through Jun 2024 stood at 0.07 (down 83.14% YoY), while the FY2023 annual figure was 1.13, up 297.36% from the prior year.
- Debt Ratio for Q2 2024 stood at 0.07, down from 0.1 in the prior quarter.
- The five-year high for Debt Ratio was 1.13 in Q4 2023, with the low at 0.07 in Q2 2024.
- The 5-year median for Debt Ratio is 0.19 (2020), against an average of 0.28.
- The sharpest annual moves came in 2023 and 2024: Debt Ratio jumped 297.36% in 2023, then sank 83.14% in 2024.
- Corbus Pharmaceuticals Holdings' Debt Ratio stood at 0.18 in 2020, then dropped by 1.36% to 0.17 in 2021, then surged by 62.9% to 0.28 in 2022, then surged by 297.36% to 1.13 in 2023, then plunged by 93.72% to 0.07 in 2024.
- Business Quant data shows CRBP's Debt Ratio at 0.07 in Q2 2024, 0.1 in Q1 2024, and 1.13 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 0.47 |
| 10 | Corbus Pharmaceuticals Holdings | 127.75 Mn | -35.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 1.13 |
| Sep 30, 2023 | 0.49 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.28 |
| Sep 30, 2022 | 0.26 |
| Jun 30, 2022 | 0.23 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.17 |
| Sep 30, 2021 | 0.16 |
| Jun 30, 2021 | 0.15 |
| Mar 31, 2021 | 0.13 |
| Dec 31, 2020 | 0.18 |
| Sep 30, 2020 | 0.19 |
| Dec 31, 2013 | 1.08 |